Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive

Autor:	PR Newswire
Zdroj:	PR Newswire US. 01/24/2011.
Abstrakt:	SAN DIEGO, Jan. 24, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr. Dennis Fenton, long-time Amgen executive, to the company's Board of Directors. Dr. Fenton's appointment expands the Genelux Corporation board to 5 members. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.